Comparison
Cortellis and DRG, the former Clarivate Life Sciences & Healthcare products owned by Altaris since 6 October 2026, are curated databases for R&D, regulatory and market-access teams; Salesmotion is AI account intelligence for the BD and sales teams selling into those companies. The Cortellis and DRG business does not publish pricing, while Salesmotion starts at $85/month on a monthly contract.
By Semir JahicCEO & Co-Founder, SalesmotionLast reviewed | Feature | Clarivate Life Sciences (Cortellis, DRG) | Salesmotion |
|---|---|---|
| Primary Function | Proprietary life sciences data & analytics | AI account intelligence & selling signals |
| Core Audience | Pharma R&D, regulatory affairs, commercial strategy | BD, sales, and commercial teams |
| Data Sources | Proprietary curated databases (Cortellis, DRG) | 1,000+ public sources, each data point linked to its source |
| Clinical Trials | Cortellis Clinical Trials Intelligence (proprietary curation) | Trials consolidated from ClinicalTrials.gov and public registries |
| Pricing | Custom, enterprise-only | $85/mo for individuals. Custom pricing for teams & enterprise. |
| Rating (G2) | — | 4.8/5 |
The Cortellis and DRG products are no longer owned by Clarivate: Clarivate completed the sale of its Life Sciences & Healthcare business to Altaris, LLC for $600 million on 6 October 2026, and the business now operates as an independent company. It is still presented at clarivate.com/life-sciences-healthcare, where it says it serves more than 3,000 life sciences clients.
The portfolio is a set of curated data and analytics products for life sciences organizations. Cortellis covers Competitive Intelligence, Deals Intelligence, Product Intelligence, CMC Intelligence, Drug Discovery Intelligence, Clinical Trials Intelligence and Regulatory Intelligence. DRG covers Market Assessment, Epidemiology Intelligence and Fingertip, with DRG Fusion for real-world data and commercial analytics. The portfolio also includes BioWorld news, OFF-X Translational Safety Intelligence, Market Access Intelligence and MetaCore.
Its strength is proprietary, curated datasets in pipeline, regulatory and market-access intelligence, supported by expert consultants. The business describes AI-powered intelligence platforms and AI-assisted regulatory intelligence, and offers APIs and data products to integrate its data with a client's own portals, dashboards and systems.
Best for: Pharma R&D, regulatory affairs and commercial strategy teams that need proprietary drug pipeline, clinical trial, regulatory and market-access data
Pricing: The former Clarivate Life Sciences & Healthcare business (Cortellis, DRG), owned by Altaris since October 2026, does not publish list pricing; contracts are quoted per organization.
Salesmotion is an AI account intelligence platform that helps sales, BD and commercial teams research accounts, track buying signals and personalize outreach from publicly available sources. Three AI agents (Signal, Research and Outreach) turn 1,000+ sources, including news, earnings calls, job postings, press releases, SEC filings, clinical trial registries and leadership changes, into cited account briefs and drafted outreach.
Salesmotion is built on public data. It scans and consolidates clinical trial data from ClinicalTrials.gov and equivalent public registries, alongside live signal monitoring across its other sources, and links every data point to where it came from. That gives life sciences BD and sales teams the account context they need for selling, in a tool that is up and running in minutes.
Cytel, a life sciences analytics company, consolidated five research sources (ZoomInfo, Crunchbase, SEC.gov, Google News and ClinicalTrials.gov) into Salesmotion and cut research time by 50%. The platform is used by CROs, biotech companies and pharma commercial teams that need account intelligence for selling.
Best for: Life sciences BD, sales and commercial teams that need account intelligence, buying signals and personalized outreach on a published, monthly price
G2 rating: 4.8/5
Pricing: $85/mo for individuals — flexible monthly billing. Custom pricing for teams and enterprise on request.
How Clarivate Life Sciences (Cortellis, DRG) and Salesmotion stack up across key capabilities.
| Feature | Clarivate Life Sciences (Cortellis, DRG) | Salesmotion |
|---|---|---|
| Drug Pipeline Data | Cortellis pipeline and drug-discovery intelligence | Pipeline tracking from public registries, news, and press releases |
| Regulatory Intelligence | Cortellis Regulatory Intelligence (global) | FDA/EMA news monitoring via public sources |
| Real-World Data | DRG Fusion real-world data and commercial analytics | Built on public sources; pairs with a real-world data provider |
| Account Research | Built for R&D, regulatory and market-access research | Cited AI briefs from 1,000+ sources |
| Buying Signals | Deals, pipeline and trial intelligence within Cortellis; BioWorld news | 50+ signal types: earnings, hiring, leadership, news, trials |
| Beyond the Data | Expert consulting for market access and pricing | Outreach Agent drafts anchored to account research, pushed to lemlist |
| Integration | APIs and data products for integration into client systems | Native Salesforce integration; HubSpot integration; REST API and MCP server |
| Cross-Signal Search | Separate Cortellis and DRG intelligence products | Full-text search across all data types and accounts |
| How You Buy | Quoted per organization | Published price; monthly contract |
We held 55 sales and customer calls between August and October 2026, 17 of them with life sciences teams. They asked for current, traceable data and fewer tools to cross-check.
“it's a whole lot of Frankensteining ... having to go to multiple sources just to confirm each step of the way”
“So how confident are you that your data is up to date?”
“without having to duplicate the task between your solution and our internal sales tool.”
The former Clarivate Life Sciences & Healthcare business (Cortellis, DRG), owned by Altaris since October 2026, does not publish list pricing; contracts are quoted per organization. The business has been owned by Altaris since the sale closed on 6 October 2026.
Salesmotion publishes its price: $85/mo for individuals — flexible monthly billing. Custom pricing for teams and enterprise on request. There is no annual commitment on the individual plan and no implementation project.
The honest trade-off: Cortellis and DRG offer proprietary curated data, particularly regulatory intelligence, real-world data and drug pipeline detail, built for R&D and market-access decisions. Salesmotion is built for account intelligence, buying signals, meeting prep and outreach personalization. Many life sciences teams keep selective proprietary data subscriptions and use Salesmotion for day-to-day account intelligence. See how Cytel consolidated five research sources into Salesmotion.
We'd rather you pick the right tool than the wrong one. Salesmotion isn't for everyone — here's when another option on this page is the smarter call.
“All of the vendors that I've worked with, all of the onboarding that I have had to deal with, I will say, hands down, Salesmotion was the easiest that I have had.”
Lyndsay Thomson
Head of Sales Operations, Cytel
Salesmotion gives your reps the account intelligence they need to book more meetings and close bigger deals.
Altaris. Clarivate completed the sale of its Life Sciences & Healthcare business, which includes Cortellis, DRG and BioWorld, to Altaris, LLC on 6 October 2026 for $600 million. The deal was announced on 6 July 2026. The business now operates as an independent company and is still presented at clarivate.com/life-sciences-healthcare.
Cortellis and DRG pricing is not published. The former Clarivate Life Sciences & Healthcare business (Cortellis, DRG), owned by Altaris since October 2026, does not publish list pricing; contracts are quoted per organization. Salesmotion publishes its price: $85/mo for individuals — flexible monthly billing. Custom pricing for teams and enterprise on request.
It depends on what you use them for. If your team relies on proprietary drug pipeline data (Cortellis), real-world data and commercial analytics (DRG Fusion) or curated regulatory intelligence, keep them: Salesmotion is built on public sources. If your use case is account research, buying signals, meeting prep and outreach for BD and sales, Salesmotion is built for that. Cytel, for example, consolidated five research sources (ZoomInfo, Crunchbase, SEC.gov, Google News and ClinicalTrials.gov) into Salesmotion and cut research time by 50%.
Salesmotion scans and consolidates clinical trial data from ClinicalTrials.gov and equivalent public registries, as well as FDA and EMA announcements, company press releases and news coverage. It tracks when target accounts start new trials, hit milestones or announce results, and turns that into account-level intelligence with talking points. Cortellis Clinical Trials Intelligence adds proprietary curation on top of the public record, which is what R&D teams buy it for.
For BD and sales teams at CROs, CDMOs and biotech companies selling into pharma, Salesmotion is built for the selling motion: cited account briefs, 50+ signal types including clinical trial activity, and drafted outreach. R&D, regulatory and market-access teams that need curated proprietary data are better served by Cortellis and DRG.
Yes. Cytel is the flagship life sciences example. Salesmotion's clinical trial monitoring, earnings call analysis and leadership tracking are relevant for CROs, CDMOs and biotech companies selling into pharma accounts, and the monthly contract from $85/month lets a team start without a long procurement cycle.
A Signal Agent, Research Agent, and Outreach Agent — working every day so your team spends less time researching and more time closing.
